OH-PROCTER-&-GAMBLE
5.8.2021 20:51:08 CEST | Business Wire | Press release
As an Olympic sponsor for the past 10 years, Procter & Gamble’s (NYSE: PG) focus is on celebrating and supporting the unique journeys athletes take on the road to their Olympic dreams, including the causes they champion and the work they do to drive positive change in their communities. In the lead up to the Olympic Games Tokyo 2020, P&G was inspired by the selfless actions of Olympic and Paralympic athletes around the world who stepped up and served others. This led P&G to create the Athletes for Good Fund in partnership with the International Olympic Committee (IOC) and International Paralympic Committee (IPC). Its purpose is to honor and fuel the work of Olympic and Paralympic athletes and hopefuls who lend their time, talent, and resources to charitable causes in the areas of Community Impact, Equality & Inclusion, and Environmental Sustainability. For Tokyo 2020, Athletes for Good Fund provided more than $500,000 in grants to help fuel the efforts of the recipients’ charities of choice.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210805005996/en/
Today, during a virtual panel discussion dubbed “Champions and the Causes They Champion,” co-hosts Olympic Gold Medalist Nastia Liukin (USA, Gymnastics Legend) and Olympic Silver Medalist Gus Kenworthy (Great Britain, Freestyle Skiing) were joined by four athletes who are not only incredible competitors, but also display compassion, humanity, and goodness on and off the field of play. Through their inspiring stories, we learned how each panelist found motivation based on their personal experiences, along with their passion to get involved to create positive change within their communities. Panelists included:
- Mariah Duran* , USA, Skateboarding: Having experienced firsthand the intimidation of competing in a male-dominated sport with few female mentors, Mariah serves as a role model, mentor, and advocate for young girls in skate. Through her work with Skate Like A Girl, she encourages the next generation of girls to continue pursuing their passion.
- Alice Dearing* , Great Britain, Swimming: As the first Black woman to swim for Team Great Britain at any Olympic Games, Alice has experienced the barriers within the sport of swimming that are faced among people of color. Taking matters into her own hands, Alice is a lead ambassador for the Black Swimming Association (BSA), focusing on increasing participation and changing attitudes to attract more Black people to understand the importance of learning to swim.
- Brian Afanador* , Puerto Rico, Table Tennis: After Hurricane Maria left a devastating effect on Puerto Rico, Brian used his platform as an Olympic athlete to expand awareness to help his community. In collaboration with #Yonomequito Foundation, he has helped to rebuild homes and provide necessities, like food, fresh water, and emergency services to local families in need.
- Erica Sullivan , USA, Swimming: As an openly gay, Asian American swimmer, Erica has stepped up to advocate for intersectional equality in sport. During Tokyo 2020, she used her press conference as an opportunity to bring awareness to minority groups, including the LGBTQ+ community.
“The spirit of the Olympic Games has the power to lift us up and unite us, and these incredible athletes have all taken that spirit beyond the Olympic and Paralympic Movement, and into their communities with a goal of creating positive change,” said host Nastia Liukin. “It’s inspiring to see organizations, like P&G, continuing to celebrate athletes both on and off the field, supporting their efforts to fuel good in communities so others will be inspired to do the same.”
“For me, being an Olympian is much more than just excelling at my sport; it’s also about using my platform to help the next generation of women skaters coming up reach their potential and dream big,” Mariah Duran shared. “I would not be where I am today without the community and experiences I got at Skate Like A Girl. This organization is a prominent voice for gender equality and inclusion in skateboarding and their events, camps and after school programs help make an unreal scenario, real. I am so appreciative of P&G and Athletes for Good for supporting them.”
You can view the full panel conversation here .
*Athletes for Good Fund Grant recipient
Spotlighting Those Who Lead with Love During Tokyo 2020
Throughout Tokyo 2020, P&G took its commitment to supporting athletes a step further by donating an additional two grants to the chosen charities of athletes who used their Olympic Games platform to serve and support others in Tokyo. Along with Erica Sullivan, P&G extended a donation to Pita Taufatofua (Tonga, Taekwondo), who inspired people everywhere with his generosity towards the athlete community on the ground in Tokyo. The three-time Olympian, who has 15 years of volunteer experience in the youth mental health space, publicly recognized the immense amount of pressure that athletes are put under when competing at an elite level and invited athletes to reach out to him for counseling and advice. His call to action resulted in hundreds of exchanges with athletes, both via social media and in-person at Tokyo 2020. For his efforts to serve as a sounding board for athletes and provide an uplifting voice of support, P&G is proud to recognize that the good that Pita does, is what truly makes him great.
The Athletes for Good Fund and Tokyo 2020 athlete grant donations are helping P&G to achieve its goal of reaching 2,021 Acts of Good in 2021 to support its Lead with Love campaign.
You can learn more about P&G’s Lead with Love commitment here: https://us.pg.com/lead-with-love/ .
About P&G’s 2,021 Acts of Good in 2021
At P&G, supporting our communities, fostering equality and inclusion, and protecting the planet is embedded in how we do business. We believe we have a responsibility to help improve everyday life — through the products we create and the positive impact our brands and Company can have. Under our Lead with Love campaign, P&G and its brands have committed to 2,021 acts of good this year.
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com/ for the latest news and information about P&G and its brands.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210805005996/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
